Valuation: EUROAPI

Market Cap 75.66M 84.37M 69.73M 63.32M 120M 7.91B 123M 835M 333M 4.24B 317M 310M 13.4B P/E 2026 *
-0.6x
P/E 2027 * -1.41x
Enterprise Value 131M 146M 121M 110M 207M 13.68B 213M 1.44B 575M 7.33B 548M 536M 23.18B EV / Sales 2026 *
0.17x
EV / Sales 2027 * 0.24x
Free-Float
64.75%
Yield 2026 *
-
Yield 2027 * -
1 day+2.59%
1 week-3.88%
Current month-4.00%
1 month+2.59%
3 months-21.58%
6 months-46.49%
Current year-65.11%
1 week 0.77
Extreme 0.768
0.84
1 month 0.71
Extreme 0.714
0.84
Current year 0.71
Extreme 0.713
2.28
1 year 0.71
Extreme 0.713
3.39
3 years 0.71
Extreme 0.713
7.02
5 years 0.71
Extreme 0.713
19.02
10 years 0.71
Extreme 0.713
19.02
Manager TitleAgeSince
Chief Executive Officer - 09/12/2024
Director of Finance/CFO - 17/10/2024
Compliance Officer - 27/11/2023
Director TitleAgeSince
Director/Board Member 62 06/05/2022
Director/Board Member - 06/05/2022
Chairman 57 09/12/2024
Date Insider Type Main position Quantity % Market Cap. Importance
1/6/23 Buy

Chief Financial Officer

617 0.0007%
1/6/23 Buy

Chief Financial Officer

620 0.0007%
1/6/23 Buy

Chief Financial Officer

617 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+2.59%-3.88%-74.81%-84.97% 82.62M
+1.44%+1.63%+48.17%+139.63% 1,258B
-0.47%+5.49%+49.03%+90.68% 679B
+0.20%+2.76%+34.37%+112.06% 518B
+0.17%+1.16%+49.70%+68.75% 390B
-0.48%+2.34%+70.66%+46.02% 367B
+0.76%+2.25%+31.84%+59.53% 307B
-1.29%+0.17%+7.63%+33.04% 293B
0.00%+0.86%+43.74%+74.04% 252B
+0.92%+2.03%+44.62%+125.07% 210B
Average +0.47%+0.32%+30.50%+66.38% 427B
Weighted average by Cap. +0.43%+1.17%+44.32%+96.37%

Financials

2026 *2027 *
Net sales 748M 834M 690M 626M 1.19B 78.23B 1.22B 8.26B 3.29B 41.91B 3.13B 3.06B 132B 748M 834M 689M 626M 1.18B 78.16B 1.22B 8.25B 3.29B 41.87B 3.13B 3.06B 132B
Net income -125M -139M -115M -104M -197M -13.02B -203M -1.37B -547M -6.97B -521M -510M -22.05B -53.63M -59.8M -49.43M -44.89M -84.95M -5.61B -87.32M -592M -236M -3B -224M -220M -9.5B
Net Debt 55.24M 61.59M 50.9M 46.23M 87.49M 5.77B 89.94M 610M 243M 3.09B 231M 226M 9.78B 105M 117M 96.61M 87.74M 166M 10.96B 171M 1.16B 461M 5.87B 439M 429M 18.56B
Projected Income Statement - Annual - EUROAPI
Logo EUROAPI
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 5 production sites located in France (2), Germany, Italy and Hungary.
Employees
2,961
Date Price Change Volume
11/11/26 EUR 0.7920 +2.59% 164,955
09/11/26 EUR 0.7720 -3.14% 317,740
06/11/26 EUR 0.7970 +0.13% 261,553
05/11/26 EUR 0.7960 -3.28% 170,181
04/11/26 EUR 0.8230 +2.11% 111,081
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - EUROAPI
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
4
Last Close Price
0.7920EUR
Average target price
1.000EUR
Spread / Average Target
+26.26%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - EUROAPI
  1. Stock Market
  2. Stocks
  3. EAPI Stock